Autoinjectors Market by Therapy (Rheumatoid Arthritis, Multiple Sclerosis, Diabetes, and Anaphylaxis), Type (Disposable, and Reusable), End Users (Home Care Settings, and Hospitals & Clinics) - Analysis & Forecast 2019-2030

Report ID : 58  |  Published Date : Apr 2019  |  Pages : 150  |  Region : Global  |  Report Code : MD-34




Autoinjectors Market Overview and Introduction

The global autoinjectors market is anticipated to witness a healthy CAGR from 2019 to 2030. 

Autoinjectors or auto-injector is a medical device, which is used to deliver a particular dosage of a drug. These devices are easy-to-handle & cost-effective and can be used by patients, caregivers, and even untrained personnel to deliver drugs of definite dosage. Autoinjectors are used for several applications, namely, rheumatoid arthritis, multiple sclerosis, diabetes, anaphylaxis, and other therapies. These devices offer multiple advantages over its conventional counterparts, namely accuracy, better efficacy, lower probability of needle-stick injuries, consistent dosage delivery, simplicity and safety among others.

The global market is driven by growing popularity of targeted therapies, increasing incidences of anaphylaxis, and rising number of regulatory approvals. Moreover, availability of generic autoinjectors of branded drugs and advent of novel technologies in the segment of drug delivery have been essential in contributing to the extensive growth of the global market. However, presence of alternative dug delivery techniques, namely syringes is likely to restrain the market to a certain extent.

Autoinjectors Market by Therapy and Type

On the basis of therapy, the global market is segmented into rheumatoid arthritis, multiple sclerosis, diabetes, and anaphylaxis. The anaphylaxis is estimated to account for the largest share in the global market. The large share of this segment can be attributed to the increasing prevalence of anaphylaxis worldwide.

On the basis of type, the market can be segmented into disposable autoinjectors, and reusable autoinjectors. In terms of market share, the segment of disposable autoinjectors is estimated to account for the largest market share, owing to ease of use and presence of a built-in glass syringe which makes these devices more convenient among patients with reduced dexterity or visual impairment.

Autoinjectors Market by End Users 

Based on the end users, the market is segmented into home care settings, and hospitals & clinics. The Home Care Settings segment is estimated to account for the largest share of the global market. The large share of this segment can be attributed to increasing awareness, rising geriatric population and benefits of using these devices without the guidance of any healthcare professionals among others.

Autoinjectors Market by Region 

The global market can be segmented into North America, Europe, Asia Pacific, and Rest of World (ROW).North America dominated the market of autoinjectors, followed by Europe and Asia Pacific. North America will continue to dominate the global autoinjectors market in the forecast period owing to factors such as, increasing incidences of anaphylaxis, growing prevalence of diabetes, rheumatoid arthritis and other ailments, and high disposable income among others. However, Asia Pacific is expected to witness the highest CAGR, with the growth in this market centered at China, Korea, Japan and India. Factors such as rising geriatric population, growing economy, increasing awareness and adoption of latest technology in the field of drug delivery systems are driving the growth of the autoinjectors market in this region.

Autoinjectors Market Prominent Players

The prominent players in the global autoinjectors market are Abbvie, Mylan, ELI Lilly, Ypsomed, Amgen, Becton Dickinson and Company, Owen Mumford, Consort Medical, Haselmeier and Shl Group among others.

Table of Contents

  1. INTRODUCTION
    1. Market Definition
    2. Market Ecosystem
      1. Market Classification
      2. Geographic Scope
      3. Years Considered for the Study: Historical Years – 2016 & 2017; Base Year – 2018; Forecasted Years – 2019 to 2030
    3. Currency Used
  2. RESEARCH METHODOLOGY
    1. Research Framework
    2. Data Collection Technique
    3. Data Sources
      1. Secondary Sources
      2. Primary Sources
    4. Market Estimation Methodology
      1. Bottoms Up Approach
      2. Top Down Approach
    5. Data Validation and Triangulation
      1. Market Forecasting Model
      2. Limitations/Assumptions of the Study
  3. ABSTRACT OF THE STUDY
  4. MARKET DYNAMICS ASSESMENT
    1. Overview
    2. Drivers
    3. Barriers/Challenges
    4. Opportunities
  5. UNIQUE SELLING PROPOSITIONS (USPs)
    1. Regulatory Landscape Assessment
    2. Epidemiological Assessment: Anaphylaxis
    3. Technological Advancements
  6. GLOBAL MARKET, BY THERAPY
    1. Rheumatoid Arthritis 
    2. Multiple Sclerosis 
    3. Diabetes
    4. Anaphylaxis 
    5. Other Therapies
  7. GLOBAL MARKET, BY TYPE
    1. Disposable 
    2. Reusable
  8. GLOBAL MARKET, BY END USER
    1. Home Care Settings
    2. Hospitals & Clinics
  9. GLOBAL MARKET - ANALYSIS & FORECAST, BY REGION
    1. North America Market
      1. North America Autoinjectors Market, By Country
        1.  US
        2.  Canada
      2. North America Market Analysis & Forecast, By Therapy
      3. North America Market Analysis & Forecast, By Type
      4. North America Market Analysis & Forecast, By End User
    2. Europe Market
      1. Europe Autoinjectors Market, By Country/Region
        1. Germany
        2. U.K
        3. France
        4. Rest of Europe (ROE)
      2. Europe Market Analysis & Forecast, By Therapy
      3. Europe Market Analysis & Forecast, By Type
      4. Europe Market Analysis & Forecast, By End User
    3. Asia Pacific Market
      1. Asia Pacific Autoinjectors Market, By Country/Region
        1. China
        2. Japan
        3. India
        4. Rest of Asia Pacific (RoAPAC)
      2. Asia Pacific Market Analysis & Forecast, By Therapy
      3. Asia Pacific Market Analysis & Forecast, By Type
      4. Asia Pacific Market Analysis & Forecast, By End User
    4. Rest of the World (ROW) Market
      1. Rest of the World Autoinjectors Market, By Country/ Region
        1. Latin America
        2. Middle East & Africa
      2. Rest of the World Market Analysis & Forecast, By Therapy
      3. Rest of the World Market Analysis & Forecast, By Type
      4. Rest of the World Market Analysis & Forecast, By End User
  10. COMPETETIVE LANDSCAPE
    1. Market Share Analysis (2018)
    2. Key Strategies Assessment
      1. New Product Launches
      2. Merger & Acquisitions
      3. Agreements, Collaborations, & Partnerships
      4. Expansions
      5. Other Strategies
  11. COMPANY PROFILES (Business Overview, Products Offered, Financial Performance, R&D Intensity, Marketing & Sales Intensity, Recent Developments, Analyst Corner)*
    1. Abbvie 
    2. Mylan
    3. ELI Lilly 
    4. Ypsomed 
    5. Amgen
    6. Becton, Dickinson and Company 
    7. Owen Mumford 
    8. Consort Medical 
    9. Haselmeier 
    10. Shl Group

*Financial details might not be captured in case of privately-held companies or forcompanies that do not report this information in public domain